#cvAFib - Twitter Hashtag

almost 3 years ago

While I spend most of my time tweeting about #cvCoag, #VTE, and #cvAFib… you have to be impressed by the future of obesity therapy, starting with the currently available GLP1-antagonist agents! Perhaps one of the biggest public health impacts of this century to date! #aha23

GBarnesMD's tweet photo. While I spend most of my time tweeting about #cvCoag, #VTE, and #cvAFib… you have to be impressed by the future of obesity therapy, starting with the currently available GLP1-antagonist agents! Perhaps one of the biggest public health impacts of this century to date! #aha23 https://t.co/mfwxZ3MaCw

0

52

9

10

5K

Geoff Barnes @GBarnesMD

almost 4 years ago · San Diego

When I was in training, we used to think rate and rhythm control were “equal” for #cvAFib. We now know that rhythm control has significant benefits! #BackToHeart22

GBarnesMD's tweet photo. When I was in training, we used to think rate and rhythm control were “equal” for #cvAFib. We now know that rhythm control has significant benefits! #BackToHeart22 https://t.co/x6chZw0DAJ

2

58

13

9

0

Geoff Barnes @GBarnesMD

about 5 years ago

@Bloodman Interesting indeed. Note that these were patients without prior stroke (when we most commonly “screen” for #cvAfib right now). Also, overall rates of AF were quite high!!

0

2

0

Viet Le DMSc PA-C FACC FAHA HF-Cert @VietHeartPA

almost 8 years ago

Biomarkers may help to id #AF pts w/asx cerebral injuries who could be at risk of subsequent neurodegen impairment, cog decline, and dementia. #cvAF #cvAfib #aha18

VietHeartPA's tweet photo. Biomarkers may help to id #AF pts w/asx cerebral injuries who could be at risk of subsequent neurodegen impairment, cog decline, and dementia. #cvAF #cvAfib #aha18 https://t.co/LlRApWkHet

0

3

2

0

Viet Le DMSc PA-C FACC FAHA HF-Cert @VietHeartPA

about 8 years ago

My #ACCCVT colleagues, always helpful to know the trial design before attempting to understand reported results! Go here👇🏽. Thanks to my friend and colleague (#CABANA investigator) @TJaredBunch. @IntermtnMedCtr @APAC_Cardiology #cvEP #cvAFib https://t.co/60gICahFow

AmericanHeartJ @AmericanHeartJ

about 8 years ago

Open Access: Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design. https://t.co/BxYSUnHvzZ

AmericanHeartJ's tweet photo. Open Access: Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design. https://t.co/BxYSUnHvzZ https://t.co/qjhRPC3UWh

0

11

6

0

2

0

Viet Le DMSc PA-C FACC FAHA HF-Cert @VietHeartPA

over 8 years ago · Murray

Congrats to my colleagues @TJaredBunch, @VE_Jacobs, and @K_Graves for their contributions to this great work! @IntermtnMedCtr #cvEP #afib #cvAFib https://t.co/5ZFJtesZmb

Thomas Jared Bunch @TJaredBunch

over 8 years ago

It was a pleasure to be part of this writing group: EHRA/HRS/APHRS/LAHRS Expert Consensus on Arrhythmias and Cognitive Function: What Is the Best Practice? https://t.co/aKEabgw5Ps